ChemoCentryx, Inc. (CCXI)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Thomas J. Schall
Employees:
180
835 INDUSTRIAL ROAD, SUITE 600, SAN CARLOS, CA, 94070
650-210-2900
ChemoCentryx, Inc. focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|